Peripheral vascular disease can be complex, but identifying and treating the challenges associated with it doesn’t have to be. Only Philips offers the powerful combination of advanced imaging and specialized treatment options to accurately assess inside the vessel, successfully select the right treatment algorithm, and optimize outcomes for your patients. Maximize your patient care. Get inside with IVUS.
Sign up for a training or connect with us at a conference to learn more.
Interested in getting hands-on experience with our products and learning more about our solutions? Join our virtual and in-person training events and connect with us at leading industry tradeshows. Check out our upcoming events below. Let us know when and where you will be joining us by tagging @PhilipsLiveFrom on Twitter!
Registration dates and locations vary for each participating society
April 25 – 27 2024 | Las Vegas, NV
May 8 – 11, 2024 | New York, NY
May 28 – 31 2024 | New Orleans, LA
To determine the right treatment path for your patient, it is critical that you first accurately assess the disease state within the vessel. That's where the powerful combination of angiography and IVUS comes into play. Angiography provides a roadmap for, and flow characteristics of, the vessel. IVUS brings you inside the vessel for deeper insights into vessel sizing and plaque morphology. IVUS and angiography give you the advanced visualization you need to deliver exceptional patient care. Watch the video to see how these two visualization tools work together to guide treatment decisions.
To determine the right treatment path for your patient, it is critical that you first accurately assess the disease state within the vessel. That's where the powerful combination of angiography and IVUS comes into play. Angiography provides a roadmap for, and flow characteristics of, the vessel. IVUS brings you inside the vessel for deeper insights into vessel sizing and plaque morphology. IVUS and angiography give you the advanced visualization you need to deliver exceptional patient care. Watch the video to see how these two visualization tools work together to guide treatment decisions.
IVUS has the potential to change treatment plans and improve patient outcomes. But don’t just take our word for it. Many clinical studies have shown the importance of using IVUS to help you visualize the best path forward – before, during, and after treatment.
global consensus guidance on IVUS3
IVUS provides you with a 360-degree vessel view, detailing vessel sizing and morphological lesion characteristics with pinpoint accuracy, allowing you to select the optimal treatment plan for your patients. Post-treatment, IVUS confirms the completeness of treatment and addresses potential dissections. Here’s how Philips' purpose-built portfolio allows you to see clearly, treat optimally.
Angiography alone cannot precisely reveal critical lesion characteristics due to its 2D view. With IVUS, you can get circumferential details about vessel sizing and plaque morphology allowing you to deliver exceptional patient care. Only Philips offers a plug-and-play platform for IVUS called Interventional Applications Workspace - IntraSight and a full line of catheters for arterial and venous interventions.
Designed for peripheral use with greater pushability for arterial interventions.
Designed to evaluate morphology and cross-sectional imaging in venous and aortic vasculature.
The only .018” OTW catheter on the market designed with outstanding deliverability and enhanced image durability for tortuous anatomy.
Rapid-exchange IVUS catheter designed to support arterial procedures.
Once inside the vessel with IVUS, detailed lesion characteristics are revealed allowing you to successfully select the appropriate crossing profile, vessel prep and definitive treatment device for personalized patient care. Only Philips offers both mechanical and laser atherectomy solutions for a comprehensive approach to efficiently tackle the spectrum of arterial morphologies. Our Philips Laser System — Nexcimer – is built on 20 years of proven technology for optimal outcomes.
A family of market defining, best-selling support catheters.
The only IVUS guided re-entry device that delivers quick, confident, and controlled true lumen re-entry.
Front-cutting mechanical atherectomy designed to cut, capture, and clear with low-risk embolization.6
Laser atherectomy catheter provides a versatile solution for debulking an array of morphologies.7,8
Laser atherectomy catheter with precise directional control backed by robust level 1 clinical data for ISR.7
Smart scoring technology delivers a unique combination of controlled, effective dilation and predictable device safety.9-13
Offers powerfully simple and cost-effective thrombus aspiration for both arterial and venous interventions.
Provides top-tier outcomes to treat common-to-complex lesions with one of the lowest therapeutic drug dose in all patients.14,15
The value of our specialized portfolio doesn’t stop with treatment. We offer several Philips-only outcome-optimizing solutions, including a dissection repair device for arterial procedures and a venous filter retrieval laser system.
First of its kind, minimal metal post-PTA precision dissection repair for ATK and BTK procedures.
The first and only FDA-cleared device designed for advanced IVC filter removal.
“Anytime that I go inside a blood vessel, I use intravascular ultrasound whether I’m reimbursed or not. That doesn’t matter to me because I know that the quality of my intervention goes up significantly, and decisions are going to be made that are different based on what I see on an intravascular ultrasound.”
Dr. Bryan T. Fisher Sr., Board Certified Vascular Surgeon and Physician Lead, HCA Healthcare in Tennessee
1. Divakaran S, Meissner MH, Kohi MP, et al. Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries. J Vasc Interv Radiol. 2022;33(12):1476-1484.e2. doi:10.1016/j.jvir.2022.08.018 2. Divakaran S, Parikh SA, Hawkins BM, et al. Temporal Trends, Practice Variation, and Associated Outcomes With IVUS Use During Peripheral Arterial Intervention. JACC Cardiovasc Interv. 2022;15(20):2080-2090. doi:10.1016/j.jcin.2022.07.050 3. Secemsky EA, Mosarla RC, Rosenfield K, et al. Appropriate Use of Intravascular Ultrasound During Arterial and Venous Lower Extremity Interventions. JACC Cardiovasc Interv. 2022;15(15):1558-1568. doi:10.1016/j.jcin.2022.04.034 4. Gagne PJ, Tahara RW, Fastabend CP, et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord. 2017;5(5):678-687. doi:10.1016/j.jvsv.2017.04.007 5. Allan R, Puckridge P, Spark J, et al. The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions. J Am Coll Cardiol Intv. 2022 Mar, 15 (5) 536–546. https://doi.org/10.1016/j.jcin.2022.01.001 6. Davis T, Ramaiah V, Niazi K, Martin Gissler H, Crabtree T. Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: Early and midterm outcomes from the prospective multicenter EASE study. Vascular. 2017 Dec;25(6):563-575 7. Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015;8(1 Pt A):92-101 8. Kuku KO, Garcia-Garcia HM, Koifman E, Kajita AH, Desale S, Azizi V, Melaku G, Bui A, Meirovich YF, Beyene S, Dheendsa A, Schneider B, Waksman R; CELLO study investigators. Intravascular ultrasound assessment of the effect of laser energy on the arterial wall during the treatment of femoro-popliteal lesions: a CliRpath excimer laser system to enlarge lumen openings (CELLO) registry study. Int J Cardiovasc Imaging. 2018 Mar;34(3):345-352. doi: 10.1007/s10554-017-1248-2. Epub 2017 Sep 26. PMID: 28952037; PMCID: PMC5847219. 9. Kiesz RS, Scheinert D, Peeters PJ, et al. Results from the international registry of the AngioSculpt Scoring Balloon Catheter for the treatment of infrapopliteal disease. J Am Coll Cardiol. 2008;51:10 (suppl B);75. 10. Scheinert D, Peeters P, Bosiers M, et al. Results of the multicenter first-in-man study of a novel scoring balloon catheter for the treatment of infra-popliteal peripheral arterial disease. Catheter Cardiovasc Interv. 2007;70:1034-1039. 11. AngioSculpt Test Plan ST-1197 (2008), on file at Philips. 12. Bosiers et al, Use of the AngioSculpt Scoring Balloon for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: 1-year Outcome Vascular, Vol. 17. No. 1, pp. 29-35. 2009. 13. MASCOT Presented at Veith 2009 (NYC, NY) and CRT 2010 (Washington, DC) 14. Schroeder H, Werner M, MD, Meyer D-R, Reimer P, Krüger K, Jaff M, Brodmann M, et al. Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon). Circulation AHA. 2017; 35(23): 2227-2236 doi:10.1161/CIRCULATIONAHA.116.026493 15. Lyden SP, Brodmann M, Schroeder H, Holden A, Ouriel K, Tarra TR,Gray WA, et al. Five-Year Independent Patient-Level Mortality Analysis of the PooledILLUMENATE Pivotal and EU Randomized Controlled Trials. J Society for Cardiovascular Angiography & Interventions (JSACI). 2017; 2(4), 100634. DOI:https://doi.org/10.1016/j.jscai.2023.100634
You are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueSelect country
United States (English)